Nutrition and Health – Transforming Research Traditions

Critical Reviews in Food Science and Nutrition

Volumn 55, Issue 8, 2015, Pages 1074-1080

  Hanekamp, Jaap C ^a,c   Bast, Aalt ^b   Calabrese, Edward J ^c  

^a Roosevelt Academy   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

benefits assessment; biological plasticity; biphasic dose response; dose response; health; health claims; intrinsic health capacity; Nutrition; one hit model; polyphenols

Indexed keywords

ACCIDENT PREVENTION; HEALTH;

BENEFITS ASSESSMENT; DOSE RESPONSE; HEALTH CLAIMS; INTRINSIC HEALTH CAPACITY; POLYPHENOLS;

NUTRITION;

FLAVONOID; POLYPHENOL;

EUROPE; FOOD; FOOD SAFETY; HEALTH PROMOTION; HEALTH STATUS; HUMAN; LAW; LEGISLATION AND JURISPRUDENCE; NUTRITION; NUTRITIONAL SCIENCE; NUTRITIONAL STATUS; RISK ASSESSMENT; TRENDS;

EUROPE; FLAVONOIDS; FOOD; FOOD SAFETY; HEALTH PROMOTION; HEALTH STATUS; HUMANS; LEGISLATION, FOOD; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; NUTRITIONAL SCIENCES; NUTRITIONAL STATUS; POLYPHENOLS; RISK ASSESSMENT;

EID: 84955345012     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2012.680525     Document Type: Article

References (45)

1. Abou El Hassan, M.A., Verheul, H.M., Jorna, A.S., Schalkwijk, C., van Bezu, J., (2003). The new cardioprotector monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro. Br. J. Cancer. 89:357–362.
2. Althaus, C.E. (2005). A disciplinary perspective on the epistemological status of risk. Risk Anal. 25(3):567–588.
3. Asp, N.G., Cummings, J.H., Mensink, R.P., Prentice, A., Richardson, D.P., and Saris, W.H. M. (Eds) (2003). Passclaim - process for the assessment of scientific support for claims on foods. Phase one: Preparing the way. Eur. J. Nutr. 42, Suppl 1.
4. Bailey, S.J., Winyard, P., Vanhatalo, A., Blackwell, J.R., DiMenna, F.J., (2009). Dietary nitrate supplementation reduces the O2 cost of low-intensity exercise and enhances tolerance to high-intensity exercise in humans. J Appl Physiol 107:1144–1155.
5. Boots, A.W., Li, H., Schins, R.P., Duffin, R., Heemsker, J.W., (2008a). The quercetin paradox. Toxicol. Appl. Pharmacol. 222:89–96.
6. Boots, A.W., Haenen, G.R. and Bast, A. (2008b). Health effects of quercetin: From antioxidant to nutraceutical. Eur. J. Pharmacol. 585:325–337.
7. Boots, A.W., Wilms, L.C., Swennen, E.L., Kleinjans, J.C., Bast, A. and Haenen, G.R. (2008). In vitro and ex vivo anti-inflammatory activity of quercetin in healthy volunteers. Nutr. 24:703–710.
8. Boudreau, F.G. (1947). Nutrition in war and peace. Milbank Q 25(3):231–246. Italics added.
9. 01 study. Why the society of toxicology became involved. Fundam Appl. Toxicol. 1:26–128.
10. Calabrese, E.J. and Baldwin, L. (1997). The dose determines the stimulation (and poison): Development of a chemical hormesis database. Int. J. Tox. 16:545–559.
11. Calabrese, E.J. and Baldwin, L.A. (1998). A general classification of U-shaped dose-response relationships. Human Exp. Tox. 17:353–364.
12. Calabrese, E.J. and Baldwin, L.A. (2001). Hormesis: A generalizable and unifying hypothesis. Crit. Rev. Tox. 31(4&5):353–424.
13. Calabrese, E.J. and Blain, R. (2005). The occurrence of hormetic dose-responses in the toxicological literature, the hormesis database: An overview. Tox. Appl. Pharm. 202:289–301.
14. Calabrese, E.J., Staudenmayer, J.W., Stanek, E.J. and Hoffmann, G.R. (2006). Hormesis outperforms threshold model in NCI anti-tumor drug screening data. Tox. Sci. 94:368–378.
15. Calabrese, E.J., Bachmann, K.A., Bailer, A.J., Bolger, P.M., Borak, J., (2007). Biological stress terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. Tox. Appl. Pharm. 222:122–128.
16. Calabrese, E.J. and Mattson, M.P. (2011). Hormesis provides a generalized quantitative estimate of biological plasticity. J. Cell. Commun. Signal 5:25–38.
17. Chalmers, A. (1989). How to defend science against scepticism: A reply to Barry Gower. Br. J. Phil. Sci. 40:249–253.
18. Cramer, G.M., Ford, R.A. and Hall, R.L. (1978). Estimation of toxic hazard—a decision tree approach. Food Cosmet. Tox. 16:255–276.
19. Cummings, J.H., Pannemans, D. and Persin, C. (2003). Passclaim – Report of the first plenary meeting including a set of interim criteria to scientifically substantiate claims on foods. Eur. J. Nutr. 42(Suppl 1):112–119.
20. th of May 2011).
21. Gezondheidsraad. Leidraad classificatie carcinogene stoffen. (2010). Den Haag: Gezondheidsraad, publikatienr. A10/07.
22. Godfrey-Smith, P. (2003). Theory and Reality. An Introduction to the Philosophy of Science, p. 211. The University of Chicago Press, Chicago.
23. Griffiths, H.R., Møller, L., Bartosz, G., Bast, A., Bertoni-Freddari, C., (2002). Biomarkers. Mol. Aspects Med. 23:101–208.
24. Hanekamp, J.C. and Bast, A. (2006). Food supplements and fortified foods: The EC's patriarchal precautionary perspectives on public health. Env. Liab. 5:181–191.
25. Hanekamp, J.C. and Bast, A. (2007). Food Supplements and European Regulation within a Precautionary Context: A Critique and Implications for Nutritional, Toxicological and Regulatory Consistency. Crit. Rev. Food. Sci. 47:267–285.
26. Hanekamp, J.C. and Bast, A. (2008). Why RDA's and UL's are incompatible standards in the U-Shape Micronutrient Model. A philosophically orientated analysis of micronutrients standardisations. Risk Anal. 28(6):1639–1652.
27. Harper, A.E. (1987). Evolution of Recommended Dietary Allowances–New Directions? Ann. Rev. Nutr. 7:509–537.
28. Heaney, R. (2008). Nutrients, endpoints, and the problem of proof. J. Nutr. 138:1591–1595.
29. Heiss, C., Finis, D., Kleinbongard, P., Hoffmann, A., Rassaf, T., (2007). Sustained increase in flow-mediated dilation after daily intake of high-flavanol cocoa drink over 1 week. J. Cardiovasc. Pharm. 49:74–80.
30. Hooper, L., Kroon, P.A., Rimm, E.B., Cohn, J.S., Harvey, I., (2008). Flavonoids, flavonoid-rich foods, and cardiovascular risk: A meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 88:38–50.
31. Izem, R. and Kingsolver, J.G. (2005). Variation in continuous reaction norms: Quantifying directions of biological interest. Amer. Nat. 166:276–289.
32. James, P., Kemper, F. and Pascal, G. (1999) A European Food and Public Health Authority. The future of scientific advice in the EU, p. 42.
33. Leitch, I. (1942). The Evolution of Dietary Standards. Nutr. Abstracts Rev. 11(4):509–521.
34. Link, A., Balaguer, F. and Goel, A. (2010). Cancer chemoprevention by dietary polyphenols: Promising role for epigenetics. Biochem. Pharmacol. 80:1771–1792.
35. Lundberg, J.O., Carlström, M., Larsen, F.J. and Weitzberg, E. (2011). Roles of dietary inorganic nitrate in cardiovascular health and disease. Cardiovasc Res. 89:525–532.
36. Pigliucci, M., Murren, C.J. and Schlichting, C.D. (2006). Phenotypic plasticity and evolution by genetic assimilation. J. Exp. Biol. 209:2362–2367.
37. Platt, J.R. (1964). Strong Inference. Science 146:347–252.
38. Regulation 1924/2006 Of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims on foods. O J L404.
39. Schulz, K.F., Altman, D.G. and Moher, D. (2010). CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. BMJ 340. doi:10.1136/bmj.c332.
40. Scientific Opinion. (2010). Guidance on human health risk-benefit assessment of foods. EFSA J. 8(7):1673.
41. Steffen, Y., Gruber, C., Schewe, T. and Sies, H. (2008). Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch Biochem. Biophys. 468:209–219.
42. Van Acker, S.A., van den Berg, D.J., Tromp, M.N., Griffioen, D.H., van Bennekom, W.P., (1996). Structural aspects of antioxidant activity of flavonoids. Free Radic. Biol. Med. 20:331–342.
43. Weseler, A.R. and Bast, A. (2010). Oxidative stress and vascular function: Implications for pharmacologic treatments. Curr. Hypertens. Rep. 12:154–161.
44. Weseler, A.R., Ruijters E.J. B., Drittij-Reijnders M.-J., Reesink K.D., Haenen G.R. M. M. and Bast, A. (2011). Pleiotropic benefit of monomeric and oligomeric flavanols on vascular health - A randomized controlled clinical pilot study. PLoS ONE. 6(12):e28460. doi:10.1371/journal.pone.0028460
45. Zwarenstein, M., Treweek, S., Gagnier, J.J., Altman, D.G., Tunis, S., (2008). Improving the reporting of pragmatic trials: An extension of the CONSORT statement. BMJ. 337: doi: 1o.1136/bmj.a2390.